CD28 and neoplasm: In this study, we developed a method to generate TITR mimics from peripheral blood mononuclear cell (PBMC)-derived Tregs, employing CD3/CD28 activator, interleukin 2 (IL-2), vitamin D3 (VitD3) and tumor cell-conditioned medium (TCM).